|Cheng Cameron Yin|
The University of TexasUpon completion of a MD at Beijing Medical University and a PhD in Pathology at the University of Wisconsin-Madison, Dr. Yin pursued her clinical residency training in Anatomic and Clinical Pathology, followed by two fellowships in Hematopathology and Molecular Genetic Pathology, respectively, at the University of Texas M.D. Anderson Cancer Center (MDACC). She is board certified by the American Board of Pathology in Anatomic Pathology, Clinical Pathology, Hematology and Molecular Genetic Pathology. Dr. Yin is an associate professor in the Department of Hematopathology at MDACC and an associate professor at UT Graduate School of Biomedical Sciences. In addition to clinical service and fellowship and postdoctoral education, Dr. Yin has been actively participating in multiple research projects in leukemia and lymphoma, which has led to over 50 research papers and editorial reviews, as well as 16 book chapters. She serves as members of editorial boards or reviewers for over 10 journals.
Mechanisms of imatinib resistance in patients with chronic myelogenous leukemia, Molecular monitoring of responses to kinase inhibitors in chronic myelogenous leukemia, Clinical, morphologic and molecular genetic features of acute myeloid leukemia, Immunoglobulin gene rearrangement in acute myeloid leukemia, Clinical, morphologic and molecular genetic features of a variety of lymphomas, Molecular markers as a tool in the diagnosis, targeted therapy and prognosis in cancer.